← Leaderboards
Julie L. Christensen
Cellerant Therapeutics, Inc.
$594,835
Attributed
$594,835
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2007–08$500K$375K$250K$125K$0
'07
'08
Funding mix
By agency
NIH$594,835 · 1
By mechanism
R41$594,835 · 1
Top collaborators
No co-investigators on record.
Most similar at Cellerant Therapeutics, Inc.
Same institution · by research overlap
- Holger Karsunky$3,179,282
- Adrianus G.w. Domen$658,973
- Ramkumar K Mandalam$2,045,696
- Swapna Panuganti$558,580
- Timothy Cheng Fong$100,394
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAllogenicAspergillus FumigatusAttenuatedAttenuationBacterial TranslocationBaseBiodefenseBlood PlateletsCellsCell TransplantationCessation Of LifeChemokineCoagulation ProcessCollaborationsConditionConditioningConsultCryopreservationCytokineDendritic CellsDisastersDisruptionAccidents, Nuclear Reactor